Molecular Diagnostics Quality Control

QC Basics - Error Erasers

• Definition: System ensuring molecular test reliability, accuracy, and reproducibility. Essential for valid patient results.
• Goal: Detect & minimize errors across all test phases (pre-analytical, analytical, post-analytical).
• Error Types:
  • Pre-analytical: Sample issues (collection, transport, storage). Most frequent.
  • Analytical: Assay performance (reagents, equipment, technique).
  • Post-analytical: Data handling, result interpretation & reporting.
• Key Metrics:
  • Accuracy: Closeness to true value.
  • Precision (Reproducibility): Consistency of results.
  • Sensitivity & Specificity: Diagnostic power.
• Tools: Controls (monitor test runs), calibrators (standardize assays), proficiency testing (external assessment).

⭐ Pre-analytical errors constitute the largest source of laboratory errors, often exceeding 60-70%.

Pre-Analysis QC - Specimen Sentinels

• Critical first step; "Garbage In, Garbage Out" (GIGO) principle applies. Errors here are often irreversible, impacting downstream molecular assays.
• Core Areas:
  • Patient Identification: At least 2 unique identifiers (e.g., name, DOB, MRN). Barcoding preferred.
  • Specimen Collection: Appropriate site, technique, correct tube (e.g., EDTA for DNA; PAXgene/RNAprotect for RNA). Prevent contamination (e.g., microbial, cross-sample).
  • Sample Volume & Quality: Sufficient quantity for planned tests. Check for hemolysis, clots, lipemia.
  • Labeling: Accurate, legible, securely attached to primary container. Must match requisition form details.
  • Transport & Handling: Maintain sample integrity. Adhere to time limits (e.g., RNA processing within 1-2 hours at Room Temperature or stabilize immediately). Strict temperature control (ambient, refrigerated, frozen as per analyte requirements).

  ⭐ Pre-analytical phase errors account for up to 70% of laboratory errors, significantly impacting molecular diagnostic accuracy.

• RNA Specifics: Extremely labile due to RNases. Use RNase-free consumables. Immediate processing or stabilization (e.g., TRIzol, PAXgene tubes) is vital.

Analysis QC - Assay Avengers

• Goal: Ensure reliable, accurate molecular test results for patient care.
• Internal Quality Control (IQC):
  • Run with each batch: Positive, Negative, Quantitative controls.
  • Tracks precision, detects systematic/random errors.
  • LJ charts + Westgard rules (e.g., 1_3s, 2_2s, R_4s) for run validation and error detection.
  • 📌 Westgard's Alerts Reveal Needy Systems (WARNS).
• External Quality Assessment (EQA) / Proficiency Testing (PT):
  • Blind sample testing by external agency.
  • Evaluates lab's accuracy and comparability vs peers.
• Calibration: Ensures instrument accuracy using calibrators/standards.
• Key Metrics for assay performance: Analytical Sensitivity (LoD), Specificity, Accuracy, Precision (CV%).

⭐ EQA participation is mandatory for NABL accreditation and reflects inter-laboratory performance.

Post-Analysis QC - Result Guardians

• Final Check: Ensures result accuracy, clinical relevance, clear & unambiguous communication.
• Key Steps: Meticulous interpretation, standardized reporting, secure archiving.
• Interpretation Process:
  • Use current databases (ClinVar, OMIM, HGMD).
  • ACMG/AMP guidelines for variant pathogenicity classification.
  • Correlate molecular findings with detailed clinical phenotype.
• Reporting Standards:
  • Clear, concise, unambiguous reports; standardized HGVS nomenclature.
  • Include: Pt/Sample ID, method, results, interpretation, limitations, recommendations.
  • Timely protocol for critical/actionable results.
• Documentation & Archiving:
  • Retain all records (raw data, analysis files, reports) per NABL/CAP.
  • LIMS for complete traceability, data integrity, audit trail.

⭐ VUS reporting: Clearly state uncertainty. Recommend genetic counseling, familial/functional studies if indicated. Avoid definitive diagnostic claims.

High‑Yield Points - ⚡ Biggest Takeaways

• Internal controls (e.g., housekeeping genes) ensure sample quality and detect PCR inhibitors.
• External controls (positive, negative) validate the entire analytical process and reagent integrity.
• Mandatory Proficiency Testing (PT/EQAS) assesses laboratory performance and ensures comparability.
• Strict adherence to SOPs is crucial for consistent and reliable results.
• Lot-to-lot reagent validation prevents performance variations and ensures accuracy.
• Monitor Analytical Sensitivity (LoD), Specificity, and Turnaround Time (TAT).